Primary Dysmenorrhea Consensus Guideline

Journal of Obstetrics and Gynaecology Canada

Volumn 27, Issue 12, 2005, Pages 1117-1130

  Guylaine Lefebvre, ^a   Odette Pinsonneault, ^a   Viola Antao, ^a   Amanda Black, ^a   Margaret Burnett, ^a   Kymm Feldman, ^a   Robert Lea, ^a   Magali Robert, ^a  

^a NONE   (Canada)

Author keywords

Crampy suprapubic pain; Duration of menses; Endometriosis; Length of cycles; Management of dysmenorrhea; Menorrhagia; Menstrual cramps; Menstrual pain; Pelvic examination; Pelvic pain; Regularity of cycles

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; GESTAGEN; GLYCERYL TRINITRATE; LEVONORGESTREL; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; PARACETAMOL;

ACUPUNCTURE; ALTERNATIVE MEDICINE; ARTICLE; BEHAVIOR THERAPY; DIFFERENTIAL DIAGNOSIS; DRUG SAFETY; DYSMENORRHEA; HUMAN; HYSTERECTOMY; INTERMETHOD COMPARISON; KINESIOTHERAPY; LABORATORY TEST; LAPAROSCOPIC SURGERY; LAPAROSCOPY; LIFESTYLE MODIFICATION; MANAGED CARE; MANIPULATIVE MEDICINE; MEDICAL HISTORY; NEURECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PRESACRAL NEURECTOMY; RISK BENEFIT ANALYSIS; RISK FACTOR; THERMOTHERAPY; TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION; TREATMENT OUTCOME; FEMALE; QUALITY OF LIFE;

DIAGNOSIS, DIFFERENTIAL; DYSMENORRHEA; FEMALE; HUMANS; QUALITY OF LIFE; RISK FACTORS;

EID: 84971420310     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)30395-4     Document Type: Article

References (126)

1. Akerland M Pathophysiology of dysmenorrhea. Acta Obstet Gynecol 1979, 87(Suppl):27-32.
2. Rosenwaks Z, Seegar-Jones G Menstrual pain: its origin and pathogenesis. J Repród Med 1980, 25(4):207-212.
3. Jamieson DJ, Steege JF The prevalence of dysmenorrhea, dyspareunia, pelvic pain, and irritable bowel syndrome in primary care practices. Obstet Gynecol 1996, 87(l):55-58.
4. Ng TP, Tan NC, Wansaicheong GK.A prevalence study of dysmenorrhea in female residents aged 15-54 years in Clementi Town, Singapore. Ann Acad Med Singapore 1992, 21(3):323-327.
5. Strinic T, Bukovic D, Pavelic L, Herman Fajdic J, Stipic I, et al. Anthropological and clinical characteristics in adolescent women with dysmenorrhea. Coll Antropol 2003, 27(2):707-711.
6. Andersch B, Milsom I An epidemiologic study of young women with dysmenorrhea. Am J Obstet Gynecol 1982, 144(6):655-660.
7. Hirata M, Kumabe K, Inoue Y Relationship between the frequency of menstrual pain and body weight in female adolescents. Nippon Koshu Eisei Zasshi 2002, 49(6):516-524.
8. Pawlowski B Prevalence of menstrual pain in relation to the reproductive life history of women from the Mayan rural community. Ann Hum Biol 2004, 31(1):1-8.
9. Pullon S, Reinken J, Sparrow M Prevalence of dysmenorrhoea in Wellington women. N Z Med J 1988, 101(839):52-54.
10. Zondervan KT, Yudkin PL, Vessey MP, Dawes MG, Barlow DH, Kennedy SH The prevalence of chronic pelvic pain in women in the United Kingdom: a systematic review. Br J Obstet Gynaecol 1998, 105(1):93-99.
11. Hillen TI, Grbava SL, Johnson PJ, Straten JA, Keogh JM Primary dysmenorrhea in young Western Australian women: prevalence, impact, and knowledge of treatment. J Adolesc Health 1999, 25(l):40-45.
12. Burnett M, Lefebvre G, Pinsonneault O, Antao V, Black A, Feldman K, et al. Prevalence of Primary dysmenorrhea in Canada. J Obstet Gynaecol Canada 2005, 27(8):765-770.
13. Weissman AM, Hartz AJ, Hansen MD, Johnson SR The natural history of primary dysmenorrhea: a longitudinal study. Br J Obstet Gynaecol 2004, 111(4):345-352.
14. Sundell G, Milsom I, Andersch B Factors influencing the prevalence and severity of dysmenorrhoea in young women. Br J Obstet Gynaecol 1990, 97(7):588-594.
15. Harlow S, Park M A longitudinal study of risk factors for the occurrence, duration and severity of menstrual cramps in a cohort of college women. Br J Obstet Gynaecol 1996, 103(11):1134-1142.
16. Parazzini F, Tozzi L, Mezzopane R, Luchini L, Marchini M, Feldele L Cigarette smoking, alcohol consumption, and risk of primary dysmenorrhea. Epidemiology 1994, 5(4):469-472.
17. Kritz-Silverstein D, Wingard DL, Garland FC The association of behavior and lifestyle factors with menstrual symptoms. J Womens Health Gend Based Med 1999, 8(9):1185-1193.
18. Chen C, Cho SI, Damokash AI, Chen D, Li G, Wang X, et al. Prospective study of exposure to environmental tobacco smoke and dysmenorrhea. Environ Health Perspect 2000, 108(11):1019-1022.
19. Alonso C, Coe CL Disruptions of social relationships accentuate the association between emotional distress and menstrual pain in young women. Health Psychol 2001, 20(6):411-416.
20. Coco AS Primary dysmenorrhea. Am Fam Physician 1999, 60(2):489-496.
21. Iglesias EA, Coupey SM Menstrual cycle abnormalities. Diagnosis and management. Adolesc Med 1999, 10(2):255-273.
22. Banikarim C, Middleman AB Primary dysmenorrhea in adolescents. UpToDate Online 2004, 12:2.
23. Emans SJ, Laufer RL, Goldstein DP Pediatric & adolescent gynecology 2005, 417-422. Lippincott, Williams & Wilkins, Philadelphia. 5th.
24. Twigg J Dysmenorrhoea. Curr Obstet Gynaecol 2002, 12:341-345.
25. Barbieri RL Primary dysmenorrhea in adults. UpToDate Online 2004, 12:2.
26. Laufer MR, Goitein L, Bush M, Cramer DW, Emans SJ Prevalence of endometriosis in adolescent girls with chronic pelvic pain not responding to conventional therapy. J Pediatr Adolesc Gynecol 1997, 10(4):199-202.
27. Reese KA, Reddy S, Rock JA Endometriosis in adolescent population: the Emory experience. J Pediatr Adolesc Gynecol 1996, 9:125-128.
28. Jarrell JF, Vilos GA, Lea R, Leyland N, Martyn M, Lapense L, et al. SOGC Consensus Guideline for the Management of Chronic Pelvic Pain. J Obstet Gynaecol Can 2005, 27(9):869-887.
29. Campbell MA, McGrath PJ Use of medication by adolescents for the management of menstrual discomfort. Archi Pediatr Adolesc Med 1997, 151:905-913.
30. Stewart EA Adenomyosis and endometrial polyps. UpToDate Online 2003, 12:2.
31. Vilos GA, Lefebvre G, Graves GR.SOGC Clinical Practice Guideline. No. 106, August 2001. J Obstet Gynaecol Can 2001, 23(8):704-709.
32. Laufer MR Diagnosis and treatment of endometriosis in adolescents. UpToDate Online 2003, 12:2.
33. Schroeder B, Sanfilippo JS Chronic pelvic pain: medical and surgical approaches. Pediatric and adolescent gynecology 2001, 643-644. E.B. Saunders Company, Philadelphia. J.S. Sanfilippo, D. Muram, J. Dewhurst, P.A. Le (Eds.).
34. Laufer MR Identification of clear vesicular lesions of atypical endometriosis: a new technique. Fértil Steril 1997, 68(4):739-740.
35. Campbell M, McGrath P Non-pharmacologic Strategies used by adolescents for the management of menstrual discomfort. Clin J Pain 1999, 15(4):313-320.
36. Golomb L, Solidum A, Warren M Primary dysmenorrhea and physical activity. Med Sci Sports Exerc 1998, 30(6):906-909.
37. Choi P, Salmon P Symptom changes across the menstrual cycle in competitive sportswomen, exercisers and sedentary women. Br J Clin Psychol 1995, 34:447-460.
38. Metheny W, Smith R The relationship among exercise, stress and primary dysmenorrhea.] BehavMed 1989, 12(6):569-586.
39. Bolton P, Del Mar C, OiEConner V Exercise for primary dysmenorrhea (Cochrane Review). The Cochrane Library. Issue 2004, 3.
40. Dawood MY, Ramos J Transcutaneous electrical nerve stimulation (TENS) for the treatment of primary dysmenorrhea: a randomized crossover comparison with placebo TENS and ibuprofen. Obstet Gynecol 1990, 75(4):656-660.
41. Lundeberg T, Bondesson L, Lundstrom V Relief of primary dysmenorrhea by transcutaneous electrical nerve stimulation. Acta Obstet Gynecol Scand 1985, 64(6):491-497.
42. Proctor ML, Smith CA, Farquhar CM, Stones RW Transcutaneous electrical nerve stimulation and acupuncture for primary dysmenorrhea (Cochrane Review). The Cochrane Library. Issue 2004, 2.
43. Mannheimer JS, Whalen EC The efficacy of transcutaneous electrical nerve stimulation in dysmenorrhea. Clin J Pain 1985, 1(2):75-83.
44. Milsom I, Hedner N Mannheimer ?. A comparative study of the effect of high intensity TENS and oral naproxen on intrauterine pressure and menstrual pain in patients with primary dysmenorrhea. Am J Obstet Gynecol 1994, 170(l):123-129.
45. Santiesteban AJ, Burnham TL, George KL, Kita PJ, Mehring EA Primary spasmodic dysmenorrhea: the use of TENS on acupuncture points. Am J Acupunct 1985, 13(l):35-42.
46. Lewers D, Clelland J A, Jacksin JR, Varner RE, Bergman J Transcutaneous electrical nerve stimulation in the relief of primary dysmenorrhea. Phys Ther 1989, 69(l):3-9.
47. Neighbours LE, Clelland J, Jacksin JR, Bergman J, Orr J Transcutaneous electrical nerve stimulation for pain relief in primary dysmenorrhea. Clin J Pain 1987, 3:17-22.
48. Helms JM Acupuncture for the management of primary dysmenorrhea. Obstet Gynecol 1987, 69(l):51-56.
49. Proctor ML, Hing W, Johnson TC, Murphy PA Spinal manipulation for primary and secondary dysmenorrhea (Cochrane Review). The Cochrane Library. Volume 2004, 2.
50. Hondras M, Long C, Brennan P Spinal manipulative therapy versus a low force mimic maneuver for women with primary dysmenorrhea: a randomized, observer-blinded, clinical trial. Pain 1999, 81:105-114.
51. Denny DR, Gerrard M Behavioural treatments for primary dysmenorrhea: a review. Behav Res Ther 1981, 19:303-312.
52. Proctor ML Murphy PA, Pattison HM, Farquhar CM Behavioral interventions for primary and secondary dysmenorrhea (Cochrane Review). The Cochrane Library. Issue 2004, 3.
53. Akin M, Weingand K, Hengehold D, Goodale MB, Hinkle R, Smith R Continuous low-level topical heat in the treatment of dysmenorrhea. Obstet Gynecol 2001, 97(3):343-349.
54. Keays R, Williams R Acetaminophen poisoning and liver failure. Prescr J 1989, 29:155-162.
55. Karakaya G, Kalyoncu AF Acetaminophen and asthma. Expert Opin Pharmacother 2003, 4(1):13-21.
56. Janbo T, Lokken P, Nesheim BI Effect of acetylsalicylic acid, paracetamol and placebo on pain and blood loss in dysmenorrheic women. Eur J Clin Pharmacol 1978, 14:413-416.
57. DiGirolamo G, Sanchez AJ DeLosSantos AR,Gonzalez CD. Is acetaminophen, and its combination with pamabrom, an effective therapeutic option in primary dysmenorrhoea?. Expert Opin Pharmacother 2004, 5(3):561-570.
58. Teperi J, Rimpela M Menstrual pain, health and behaviour in girls. Soc Sci Med 1989, 29:163-169.
59. Zhang WY, Li Wan Po A Efficacy of minor analgesics in primary dysmenorrhoea: a systematic review. Br J Obstet Gynaecol 1998, 105:780-789.
60. Marjoribanks J, Proctor ML, Farquhar AR Nonsteroidal anti-inflammatory drugs for primary dysmenorrhoea (Cochrane Review). Cochrane Database of Systematic Reviews. Issue 2004, 2.
61. Compendium of pharmaceuticals and specialties. Ottawa: CPhA 2004, Canadian Pharmacists Association.
62. DeMello NR, Baracat EC, Tomaz G, Bedone AJ, Camargos A Barbosa 1?, et al. Double-blind study to evaluate efficacy and safety of meloxicam 7.5 mg and 15 mg versus mefenamic acid 1500 mg in the treatment of primary dysmenorrhea. Acta Obstet Gynecol Scand 2004, 83:667-673.
63. Facchinetti F, Sgarbi L, Piccinini F, Volpe A A comparison of glyceryl trinitrate with diclofenac for the treatment of primary dysmenorrhea: an open randomized, cross-over trial. Gynecol Endocrinol 2002, 16:39-43.
64. Moya RA, Moisa CF, Morales F, Wynter H, Ali A, Narancio E Transdermal glyceryl trinitrate in the management of primary dysmenorrhea. Int J Gynecol Obstet 2000, 69:113-118.
65. Proctor ML, Roberts H, Farquhar CM Combined oral contraceptive pill (OCP) as treatment for primary dysmenorrhea (Cochrane Review). The Cochrane Database of Systematic Reviews. Issue 2004, 2.
66. Ekstrom P, Akerlund M, Forsling M, Kindahl H Laudanski T, Mrugacz G Stimulation of vasopressin release in women with primary dysmenorrhea and after oral contraceptive treatment: effect on uterine contractility. Br J Obstet Gynaecol 1992, 99:680-684.
67. Chan WY, Dawood MY Prostaglandin levels in menstrual fluid of nondysmenorrheic and of dysmenorrheic subjects with and without oral contraceptive or ibuprofen therapy. Adv Prostaglandin Thromboxane Res 1980, 8:1443-1447.
68. Creatsas G, Deligeioroglou E, Zachari A, Loutradis D, Papadimitriou T Miras ?, et al. Aravantinos D. Prostaglandins: PGF2 alpha, PGE2, 6-keto-PGFl alpha and TXB2 serum levels in dysmenorrheic adolescents before, during and after treatment with oral contraceptives. Eur J Obstet Gynecol Repród Biol 1990, 36:292-298.
69. Ekstrom P, Juchnicka E, Laudanski T, Akerlund M Effect of an oral contraceptive in primary dysmenorrhea: changes in uterine activity and reactivity to agonists. Contraception 1989, 40:39-47.
70. Milsom I, Sundell G, Andrersch B The influence of different combined oral contraceptives on the prevalence and severity of dysmenorrhea. Contraception 1990, 42:497-506.
71. Robinson JC, Plichta S, Weisman CS, Nathanson CA, Ensminger M Dysmenorrhea and use of oral contraceptives in adolescent women attending a family planning clinic. Am J Obstet Gynecol 1992, 166:578-583.
72. Larsson G, Miisom I, Lindstedt G, Rybo G The influence of a low-dose combined oral contraceptive on menstrual blood loss and iron status. Contraception 1992, 46:327-334.
73. Ulstein M, Svendson E, Steier A, Bratt H, Fylling P, Lie S, et al. Clinical experience with a triphasic oral contraceptive. Acta Obstet Gynecol Scand 1984, 63:233-236.
74. Weber-Diehl Unger R Lachnit U. Triphasic combination of ethinyl estradiol and gestodene. Long-term clinical trial. Contraception 1992, 46:19-27.
75. Gauthier A, Upmalis D, Dain MP Clinical evaluation of a new triphasic oral contraceptive: norgestimate and ethinyl estradiol. Acta Obstet Gynecol Scand Suppl 1992, 156:27-32.
76. Brill K, Norpoth T, Schnitker J, Albring M Clinical experience with a modern low-dose oral contraceptive in almost 100,000 users. Contraception 1991, 43:101-110.
77. Callejo J, Diaz J, Ruiz A, Garcia RM Effect of a low-dose oral contraceptive containing 20 microg ethinylestradiol and 150 rnicrog desogestrel on dysmenorrhea. Contraception 2003, 68:183-188.
78. Hendrix SL, Alexander NJ Primary dysmenorrhea treatment with a desogestrel-containing low-dose oral contraceptive. Contraception 2002, 66:393-399.
79. Sulak P, Kuehl T, Ortiz M, Shull B Acceptance of altering the standard ' 21-day/7-day oral contraceptive regimen to delay menses and reduce hormonal withdraw symptoms. Am J Obstet Gynecol 2002, 186:1142-1149.
80. Vercellini P, Frontino G De Giorgi ?, Pietropaolo, Pasin R, Crosignani PG. Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen. Fértil Steril 2003, 80:560-563.
81. Vercellini P De Giorgi ?, Mosconi P, Stellato G, Vincentini S, Crosignani PG. Cyproterone acetate versus a continuous monophasic oral contraceptive in the treatment of recurrent pelvic pain after conservative surgery for symptomatic endometriosis. Fértil Steril 2002, 77:52-61.
82. Schwallie PC, Assenzo JR The effect of depo-medroxyprogesterone acetate on pituitary and ovarian function, and the return of fertility following its discontinuation: a review. Contraception 1974, 10:181-202.
83. Hatcher RA, Trussell J, Stewart F, Cates W, Stewart GK, Guest F, et al. Contraceptive technology 1998, Ardent Media Inc, New York.
84. Schwallie PC, Assenzo JR Contraceptive use: efficacy study utilizing medroxyprogesterone acetate administered as an intramuscular injection once every 90 days. Fértil Steril 1973, 24:331-339.
85. Polaneczky M, Guarnaccia M Early experience with the contraceptive use of depot medroxyprogesterone acetate in an inner-city clinic population. Farn Plann Perspect 1996, 28:174-178.
86. Betsey EM Menstrual bleeding patterns in untreated women and with long-acting methods of contraception. Adv Contracept 1991, 7:257-270.
87. Said S, Omar K, Koetsawang S, Kiriwat O, Srisatayapan Y, Kazi A, et al. A multicentred phase III comparative clinical trial of depot-medroxyprogesterone acetate given three-monthly at doses of 100 mg or 150 mg: 1. Contraceptive efficacy and side effects. World Health Organization Task Force on Long-Acting Systemic Agents for Fertility Regulation. Special Programme of Research, Development and Research Training in Human Reproduction. Contraception 1986, 34:223-236.
88. Critchley HO, Wang H, Jones RL, Kelly RW, Drudy TA, Gebbie AE, et al. Morphological and functional features of endometrial decidualization following long-term intrauterine levonorgestrel delivery. Hum Repród 1998, 13(5):1218-1224.
89. Barrington JW, Bowens-Simpkins P The levonorgestrel intrauterine system in the management of menorrhagia. Br J Obstet Gynaecol 1997, 104:614-616.
90. Andersson JK, Rybo G Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia. Br J Obstet Gynaecol 1990, 97:690-694.
91. Irvine GA, Campbell-Brown MB, Lumsden MA, Heikkila A, Walker JJ, Cameron IT Randomized comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia. Br J Obstet Gynaecol 1998, 105:592-598.
92. Istre O, Trolle B Treatment of menorrhagia with the levonorgestrel intrauterine system versus endometrial resection. Fértil Steril 2001, 76:304-309.
93. Pakarinen P, Toivonen J, Luukkainen T Therapeutic use of the LNG IUS, and Counseling. Sémin Repród Med 2001, 19:365-372.
94. Andersson K, Odlind V, Rybo G Levonorgestrel-releasing and copper-releasing (Nova-T) IUDs during five years of use: a randomized comparative trial. Contraception 1994, 49:56-72.
95. Ronnerdag M Odlind V. Health effects of long-term use of the intrauterine levonorgestrel-releasing system. A follow-up study over 12 years of continuous use. Acta Obstet Gynecol Scand 1999, 78:716-721.
96. Luukkainen T, Alionen H, Haukkamaa M, Holma P, Pyorala T, Terho J, et al. Effective contraception with levonorgestrel-releasing intrauterine device: 12-month report of a European multicentre study. Contraception 1987, 36(2):169-179.
97. Vercellini P, Aimi G, Panazza S, De Giorgi O, Pesóle A, Crosignani PG A levonorgestrel-releasing intrauterine system for the treatment of dysmenorrhea associated with endometriosis: a pilot study. Fértil Steril 1999, 72(3):505-508.
98. Jacobson TZ, Barlow DH, Garry R, Koninck P Laparoscopic surgery for pelvic pain associated with endometriosis (Cochrane Review). In: The Cochrane Library. Issue 3 2004, John Wiley & Sons Inc, Chichester, UK.
99. Medical Management of Endometriosis. Practice Bulletin 1999, American College of Obstetrics and Gynecology, ACOG, Washington (DC.
100. Randomized controlled trial of depot leuprolide in patients with chronic pelvic pain and clinically suspected endometriosis. Obstet Gynecol 1999, 93:51-56. Ling, FW. Pelvic Pain Study Group.
101. Sangi-Haghpeykar H, Poindexter AN Epidemiology of endometriosis among parous women. Obstet Gynecol 1995, 85:983-987.
102. Husby GK, Haugen RS, Moen MH Diagnostic delay in women with pain and endometriosis. Acta Obstet Gynecol Scand 2003, 82(7):649-653.
103. Chatman DL Ward AB. Endometriosis in adolescents. Incidence, diagnosis and treatment. J Repród Med 1982, 27:156-159.
104. Propst AM Laufer MR. Endometriosis in adolescents. Incidence, diagnosis and treatment. J Repród Med 1999, 44:751.
105. Schofield M, Bennett A, Redman S, Walters WAW, Sanson-Fisher R Self-reported long-term outcomes of hysterectomy. Br J Obstet Gynaecol 1991, 98(ll):1129-1136.
106. Rannestad T, Eikeland OF, Heiland H, Qvarnstrom U The quality of life in women suffering from gynaecological disorders is improved by means of hysterectomy: absolute and relative differences between pre- and postoperative measures. Acta Obstet Gynecol Scand 2001, 80:46-51.
107. Lefebvre G, Allaire C, Jeffrey J, Vilos G Hysterectomy. SOGC Clinical Practice Guidelines. J Obstet Gynaecol Can 2002, 109:1-11.
108. Weber AM, Walters MD, Schover LR, Church JM, Piedmonte MR Functional outcomes and satisfaction after abdominal hysterectomy. Am J Obstet Gynecol 1999, 181(3):530-535.
109. Chen FP, Chang SD, Chu KK, Soung YK Comparison of laparoscopic presacral neurectomy and laparoscopic uterine nerve ablation for primary dysmenorrhea. J Repród Med 1996, 41:463-466.
110. Zdlo F, Palomba S, Zupi E, Russo T, Morelli M Effectiveness of presacral neurectomy in women with severe dysmenorrhea caused by endometriosis who were treated with laparoscopic conservative surgery: a 1-year prospective, randomized, double-blind controlled trial. Am J Obstet Gynecol 2003, 189:5-10.
111. Zullo F, Palomba S, Zupi E, Russo T, Morelli M, Sena T, et al. Long-term effectiveness of presacral neurectomy for the treatment of severe dysmenorrhea due to endometriosis. J Am Assoc Gynecol Laparosc 2004, 11(1):23-28.
112. Proctor ML, Farquhar CM, Sinclair OJ Johnson NP. Surgical interruption of pelvic nerve pathways for primary and secondary dysmenorrhea. (Cochrane Review). In: The Cochrane Library, Issue 4 2002, Update Software, Oxford.
113. Vercellini P, Aimi G, Busacca M, Apolone G, Uglietti A, Crosignani PG Laparoscopic uterosacral ligament resection for dysmenorrhea associated with endometriosis: results of a randomized, controlled trial. Fértil Steril 2003, 80(2):310-319.
114. Gokhale LB Curative treatment of primary (spasmodic) dysmenorrhoea. Indian J Med Res 1999, 103:227-231.
115. Ziaei S, Faghihzadeh S, Sohrabvand F, Lamyian M, Emamgholy T A randomized placebo-controlled trial to determine the effect of vitamin. E in treatment of primary dysmenorrhoea. Br J Obstet Gynaecol 2001, 108:1181-1183.
116. Primary dysmenorrhea! treatment with ibuprofen and vitamin. E. Rev Obstet Ginecol Venez 1993, 53(l):35-37. Esperanza-Salazar-De-Roldan M, Ruiz-Castro S.
117. Deutch B, Jorgensen EB, Hansen JC Menstrual discomfort in Danish women reduced by dietary supplements of omega-3 PUFA and B12 (fish oil or seal oil capsules). Nutr Res 2000, 20(5):621-631.
118. Harel Z, Biro FM, Kottenhahn RK, Rosenthal SL Supplementation with omega-3 polyunsaturated fatty acids in the management of dysmenorrheal in adolescents. Am J Obstet Gynecol 1996, 174(4):1335-1338.
119. Demirturk F, Gungor T, Akbayrak T, Aker EM Relief of primary dysmenorrheal by supplementation with omega-3 fatty acids. The Pain Clinic 2002, 14(l):81-84.
120. Sampalis F, Bunea R, Pelland MF Kowalski ?, Duguet N, Dupuis S. Evaluation of the effects of Neptune krill oil on the management of premenstrual syndrome and dysmenorrheal. Altern Med Rev 2003, 8(2):171-179.
121. Seifert B, Wagler P, Dartsch S, Schmidt U, Nieder J Magnesium: a new therapeutic alternative in primary dysmenorrheal. Zentralbl gynakol 1989, 111(11):755-760.
122. Fotana-Klaiber H, Hogg B Therapeutic effects of magnesium in dysmenorrheal. Schweizerische Rundschau fur Medizin Praxis 1990, 79(16):491-494.
123. Davis LS Stress, vitamin B6 and magnesium in women with and without dysmenorrhea: a comparison and intervention study [dissertation] 1988, University of Texas at Austin, Austin (TX).
124. Kotani N, Oyama T, Sakai I, Hashimoto H, Muraoka M, Ogawa Y, Matsuki A Analgesic effect of a herbal medicine for treatment of primary dysmenorrhea-a double-blind study. American Journal of Chinese Medicine 1997, 25(2):205-212.
125. Namavar Jahromi B, Tartifizadeh A, Khabnadideh S Comparison of fennel and mefenamic acid for the treatment of primary dysmenorrhea. Int J of Gynecol Obstet 2003, 80:153-157.
126. Woolf SH, Battista RN, Angerson GM, Logan AG, Eel W Canadian Task Force on the Periodic Health Exam 1994, xxxvii. Canada Communication Group, Ottawa.